Bluejay Diagnostics, Inc. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
Bluejay Diagnostics, Inc. (BJDX) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $10.90 million as of 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2023-03-20
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $10.90M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $6.30M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $3.20M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2022-12-31 | $10.90M 10-K · filed 2023-03-20 |
| 2021-12-31 | $6.30M 10-K · filed 2023-03-20 |
| 2020-12-31 | $3.20M 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |